Background: When, as a condition of the Master Settlement Agreement in 1998, US
INTRODUCTION
Many individuals and institutions, particularly in the scientific community, choose not to accept funding from the tobacco industry [1] [2] [3] [4] . Historically the industry's reasons for funding publishable external scientific research have included building public credibility [5] [6] [7] , developing industry-friendly experts to represent them in litigation and the regulatory process [8] [9] [10] [11] and creating controversy about the health risks of active and passive smoking 7, [9] [10] [11] [12] [13] [14] . Until 1998, almost all tobacco industry funding for academic scientists came through the industry's Council for Tobacco Research (CTR) and the Center for Indoor Air Research (CIAR). These two organizations played a central role in the fraud alleged by the lawsuits brought against the tobacco industry in the 1990's. In the Master Settlement Agreement (MSA) in 1998, the tobacco companies agreed to disband the CTR and CIAR and cease sponsoring research through industry-wide groups 15 .
When the MSA forced the US tobacco companies to act independently of one another, they were left with three alternative strategies, listed in a memo to Philip Morris Vice President Denise Keane by consultant Jim Tozzi 16 :
1. establish a new program within the individual company;
2. join the efforts of an existing group; 3. establish a new organizational structure outside of the company.
The Philip Morris External Research Program (PMERP) 17, 18 is an example of a new organizational structure established outside of the company. The symposium series on inhalation toxicology funded through the International Life Sciences Institute (ILSI) by Philip Morris and RJ Reynolds 19 is an example of joining the efforts of an existing group. We describe two new industry-funded research projects: Phillip Morris' research projects on cigarette additives and reduced-risk products through the Life Sciences
Research Office (LSRO) and the Institute for Science and Health (IFSH).
METHODS
We located the documents cited in this paper by searching the 45 
RESULTS

Life Sciences Research Office (LSRO)
The (Table 2 ). Institutions and individual scientists who do not want to accept industry money [1] [2] [3] [4] and members of the public who do not want to donate to organizations funded primarily by the tobacco industry need to be aware of the new organizations the industry is channeling funding through. Regulatory officials and policy makers need to be aware that the studies being published on issues important to the industry such as cigarette additives and "potentially reduced harm products" may not be as independent as they seem.
